Physician profile
Angela S Wright
NPI 1124634787
$12,350.65
in general payments reported to CMS, 2019-2025
51 companies · $3,886 in 2025
The $3,886 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $953 · 2023: $3,175 · 2024: $4,337 · 2025: $3,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $43.71 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,329.45 |
| Education | $43.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,134.16 | 2022-2025 | Kisunla, Emgality, Amyvid |
| Ucb, INC. | $1,030.21 | 2022-2025 | Zilbrysq, Briviact, Rystiggo |
| Mdd US Operations, LLC | $935.35 | 2023-2025 | Gocovri, Gocovri, Apokyn |
| Sk Life Science, INC. | $802.81 | 2022-2025 | Xcopri |
| Emd Serono, INC. | $786.14 | 2022-2025 | Mavenclad |
| Pfizer INC. | $632.96 | 2023-2025 | |
| Amneal Pharmaceuticals LLC | $627.40 | 2022-2025 | Crexont, Rytary, Lyvispah |
| Acadia Pharmaceuticals INC | $560.92 | 2023-2025 | Nuplazid |
| Neurocrine Biosciences, INC. | $539.84 | 2022-2025 | Ingrezza, Ongentys |
| Novartis Pharmaceuticals Corporation | $531.39 | 2022-2025 | |
| Biogen, INC. | $467.13 | 2022-2025 | Vumerity, Tysabri |
| Argenx US, INC. | $427.90 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Sumitomo Pharma America, INC. | $394.01 | 2023-2024 | Aptiom |
| Genentech USA, INC. | $309.52 | 2023-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Octapharma USA, INC. | $286.08 | 2023-2025 | Panzyga, Octagam Immune Globulin (Human) |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $265.28 | 2023-2025 | |
| Axsome Therapeutics, INC. | $238.47 | 2023-2025 | Symbravo, Sunosi |
| Insightec,INC | $209.08 | 2023-2025 | Exablate |
| Takeda Pharmaceuticals U.S.A., INC. | $193.51 | 2024-2025 | Hyqvia |
| Astrazeneca Pharmaceuticals Lp | $164.22 | 2024-2025 | Wainua |
| Lundbeck LLC | $162.22 | 2023-2025 | Vyepti, Rexulti |
| Otsuka America Pharmaceutical, INC. | $160.73 | 2024 | Nuedexta, Rexulti |
| Alexion Pharmaceuticals, INC. | $157.16 | 2022-2025 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $124.74 | 2023-2025 | Austedo Xr, Austedo Xr |
| Celgene Corporation | $100.40 | 2024-2025 | Zeposia |
| Microtransponder, INC. | $93.49 | 2025 | |
| Jazz Pharmaceuticals INC. | $87.95 | 2023-2025 | |
| Abbvie INC. | $82.71 | 2024-2025 | |
| Merz Pharmaceuticals, LLC | $71.90 | 2022-2025 | Xeomin, Ampyra, Inbrija |
| Ipsen Biopharmaceuticals, INC | $64.07 | 2023-2025 | Dysport |
| Genzyme Corporation | $60.24 | 2022-2025 | |
| Amylyx Pharmaceuticals, INC. | $56.99 | 2023 | Relyvrio |
| Hologic Sales and Service, LLC | $56.60 | 2025 | Coolseal Generator |
| Biohaven Pharmaceutical Holding Company Ltd. | $49.69 | 2022 | |
| Grifols USA, LLC | $45.89 | 2025 | Gamunex-C |
| Kyowa Kirin, INC. | $43.68 | 2024 | Nourianz |
| Csl Behring | $41.84 | 2023-2025 | Hizentra, Privigen |
| Sandoz INC. | $40.29 | 2023-2024 | |
| Averitas Pharma INC. | $33.54 | 2024 | Qutenza |
| Supernus Pharmaceuticals, INC. | $33.53 | 2022 | |
| Cala Health, INC. | $31.51 | 2025 | Cala Kiq |
| Avanir Pharmaceuticals, INC. | $29.02 | 2022 | |
| Monteris Medical Corporation | $27.70 | 2025 | Neuroblate |
| Vanda Pharmaceuticals INC. | $25.63 | 2025 | Ponvory |
| Neurelis, INC. | $24.05 | 2023 | Valtoco |
| Sunovion Pharmaceuticals INC. | $21.17 | 2022 | |
| Collegium Pharmaceutical, INC. | $20.82 | 2022 | |
| Banner Life Sciences, LLC | $18.46 | 2024 | |
| Aucta Pharmaceuticals, INC. | $17.88 | 2025 | Motpoly Xr |
| Cycle Pharmaceuticals INC | $16.50 | 2024 | Tascenso Odt |
| Aprecia Pharmaceuticals, LLC | $13.87 | 2023 | Spritam |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.